Technical Analysis for SUPN - Supernus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 43.93 1.90% 0.82
SUPN closed up 1.9 percent on Friday, November 16, 2018, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical SUPN trend table...

Date Alert Name Type % Chg
Nov 16 Outside Day Range Expansion 0.00%
Nov 15 Doji - Bullish? Reversal 1.90%
Nov 13 Calm After Storm Range Contraction -2.62%
Nov 12 Calm After Storm Range Contraction -1.72%
Nov 9 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.96%
Nov 9 Calm After Storm Range Contraction -2.96%
Nov 9 Narrow Range Bar Range Contraction -2.96%
Nov 9 NR7 Range Contraction -2.96%
Nov 9 Inside Day Range Contraction -2.96%
Nov 8 Spinning Top Other -3.58%

Older signals for SUPN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing products for the treatment of central nervous system diseases. Its products include SPN-538, an extended release topiramate product that completed clinical trials in support of new drug application for the treatment of epilepsy; Epliga, an extended release oxcarbazepine, which is in Phase III clinical trials targeting epilepsy; SPN-810, a molindone hydrochloride that is in Phase II clinical trials for treatment for impulsive aggression in patients with attention deficit hyperactivity disorder; and SPN-812, a Phase II clinical trial product targeting attention deficit hyperactivity disorder. The company also develops SPN-809, which has an open investigational new drug application for the treatment of depression. It intends to market its products to specialty physicians, including neurologists and psychiatrists in the United States. The company was founded in 2005 and is based in Rockville, Maryland.
Is SUPN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 61.25
52 Week Low 34.9
Average Volume 566,613
200-Day Moving Average 48.1287
50-Day Moving Average 47.2158
20-Day Moving Average 45.5635
10-Day Moving Average 43.928
Average True Range 2.061
ADX 17.52
+DI 16.6727
-DI 27.2797
Chandelier Exit (Long, 3 ATRs ) 43.287
Chandelier Exit (Short, 3 ATRs ) 45.853
Upper Bollinger Band 49.5109
Lower Bollinger Band 41.6161
Percent B (%b) 0.29
BandWidth 17.327027
MACD Line -1.0236
MACD Signal Line -0.8682
MACD Histogram -0.1555
Fundamentals Value
Market Cap 2.23 Billion
Num Shares 50.7 Million
EPS 1.98
Price-to-Earnings (P/E) Ratio 22.19
Price-to-Sales 8.00
Price-to-Book 8.81
PEG Ratio 1.42
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.77
Resistance 3 (R3) 46.48 45.26 46.29
Resistance 2 (R2) 45.26 44.53 45.40 46.13
Resistance 1 (R1) 44.59 44.09 44.93 44.88 45.98
Pivot Point 43.37 43.37 43.53 43.51 43.37
Support 1 (S1) 42.70 42.64 43.04 42.99 41.88
Support 2 (S2) 41.48 42.20 41.62 41.73
Support 3 (S3) 40.81 41.48 41.57
Support 4 (S4) 41.10